MedTrace Logo

Effect of a Fibrate and a Statin on Endothelial Dysfunction

NCT00491400 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2012-10-24

Study results available
· View outcomes & findings →

Summary

The study will compare the effect of atorvastatin to the effect of fenofibrate on endothelial function in patients with diabetes mellitus or the metabolic syndrome.

Conditions

Interventions

DRUG

Fenofibrate

140 mg/day for 8 weeks

DRUG

Atorvastatin

20 mg/day for 8 weeks

Sponsors & Collaborators

  • Boston University

    lead OTHER

Principal Investigators

  • Joseph A Vita, MD · Boston University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00491400 on ClinicalTrials.gov